Press release
Global Study On Kaposi Sarcoma Market Size, Share, Trends, Growth and Forecast 2016 - Acute Market Reports
The report provides comprehensive information on the therapeutics under development for Kaposi Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kaposi Sarcoma and features dormant and discontinued projects.
Browse Full Report Visit - http://www.acutemarketreports.com/report/kaposi-sarcoma-pipeline-review-h1-2016
Acute Market Reports t features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Acute Market Reports proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/healthcare-market
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Kaposi Sarcoma
- The report reviews pipeline therapeutics for Kaposi Sarcoma by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Kaposi Sarcoma therapeutics and enlists all their major and minor projects
- The report assesses Kaposi Sarcoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Kaposi Sarcoma
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Kaposi Sarcoma
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Kaposi Sarcoma pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Get Complete Report @ Kaposi Sarcoma - Pipeline Review, H1 2016
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Kaposi Sarcoma Overview 7
Therapeutics Development 8
Pipeline Products for Kaposi Sarcoma - Overview 8
Pipeline Products for Kaposi Sarcoma - Comparative Analysis 9
Kaposi Sarcoma - Therapeutics under Development by Companies 10
Kaposi Sarcoma - Therapeutics under Investigation by Universities/Institutes 11
Kaposi Sarcoma - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Unknown Stage Products 14
Kaposi Sarcoma - Products under Development by Companies 15
Kaposi Sarcoma - Products under Investigation by Universities/Institutes 16
Kaposi Sarcoma - Companies Involved in Therapeutics Development 17
Aphios Corporation 17
AstraZeneca Plc 18
Biogenomics Limited 19
CytRx Corporation 20
Delenex Therapeutics AG 21
Tumorend, LLC 22
Vironika, LLC 23
Kaposi Sarcoma - Therapeutics Assessment 24
Assessment by Monotherapy Products 24
Assessment by Target 25
Assessment by Mechanism of Action 27
Assessment by Route of Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
aldoxorubicin hydrochloride - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
brolucizumab - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
CM-101 - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
CSTATI-1 - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
doxorubicin - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
interferon alfa-2a - Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
interferon alfa-2b - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
paclitaxel - Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
selumetinib sulfate - Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Small Molecule for Kaposis Sarcoma - Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
vif-1 - Drug Profile 52
Product Description 52
Mechanism of Action 52
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Office No 101, 1st Floor , Aditi Mall, Baner,
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Study On Kaposi Sarcoma Market Size, Share, Trends, Growth and Forecast 2016 - Acute Market Reports here
News-ID: 372510 • Views: …
More Releases from Acute Market Reports
Pediatric Allergy Treatment Market Set to Soar: Projected to Reach $13.9 Billion …
The pediatric allergy treatment market is experiencing significant growth, driven by the rising prevalence of allergic conditions among children. Allergies, including food allergies, allergic rhinitis, asthma, and skin allergies, are becoming increasingly common in the pediatric population. This trend has led to a growing demand for effective treatment options that can provide relief and improve the quality of life for children affected by these conditions. The market for pediatric allergy…
Strippable Coatings Market Is Expected To Expand At A CAGR Of 7.1% From 2024 To …
Strippable coatings, also referred to as peelable coatings, are a type of non-flammable, water-based protective solution that can be easily removed from surfaces without the need for harsh chemical strippers or cleaners. Composed of water-based acrylic polymers, vapor phase corrosion inhibitors, and a thixotropic thickener, these coatings enhance barrier and surface protection properties. They can be applied via brush, spray, dip, or roll and are primarily utilized on bare metal…
Bakeware Market | Global Industry Size, Development Strategy, Revenue Analysis, …
The market for bakeware is a dynamic and evolving sector that serves both commercial and residential consumers. In 2023, the bakeware market was valued at $3,850.0 million and is projected to reach $6,462.2 million by the end of 2032. This market is anticipated to grow at a compound annual growth rate (CAGR) of 5.91% during the forecast period from 2024 to 2032. The growth is largely driven by a resurgence…
Global Wire Harness Market Set to Expand Through 2032 with Major Growth Drivers …
The global wire harness market is poised for robust growth, with a projected compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth trajectory is primarily driven by significant advancements in the automotive sector, escalating demand within consumer technology, and increasing applications in aerospace and defense sectors.
In the automotive industry, the wire harness market has seen substantial growth, primarily fueled by the advent of electric vehicles (EVs)…
More Releases for Sarcoma
Emerging Trends Influencing The Growth Of The Sarcoma Drugs Market:Innovative Ge …
The Sarcoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Sarcoma Drugs Market Size Expected to Be by 2034?
The Sarcoma Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Key Influencer in the Sarcoma Drugs Market 2025: Surging Soft Tissue Sarcoma Cas …
What combination of drivers is leading to accelerated growth in the sarcoma drugs market?
The sarcoma drugs market is projected to grow due to an increase in soft tissue sarcoma cases. Soft tissue sarcoma is a type of cancer that originates in the body's soft tissues, such as muscles, fats, tendons, lymph, and nerves. Sarcoma drugs, widely utilized in the healthcare sector, treat bone and soft tissue sarcoma by targeting cancer…
Sarcoma Drugs Market Report 2024 - Sarcoma Drugs Market Growth, Trends, And Fore …
"The Business Research Company recently released a comprehensive report on the Global Sarcoma Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcoma drugs market size…
Alveolar Soft Part Sarcoma Market - Unleashing Progress: Alveolar Soft Part Sarc …
Newark, New Castle, USA: The "Alveolar Soft Part Sarcoma Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Alveolar Soft Part Sarcoma Market: https://www.growthplusreports.com/report/alveolar-soft-part-sarcoma-market/8620
This latest report researches the…
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
